WEBER, Pavel, Hana MELUZÍNOVÁ, Hana KUBEŠOVÁ, Miroslav PENKA, Jana HRUBANOVÁ and Martina ŠLECHTOVÁ. Warfarin a úskalí jeho užití ve vyšším věku (Warfarin and its drawbacks when used in old age). Geriatria. Bratislava, 2006, vol. 145, No 4, p. 150-155. ISSN 1335-1850.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Warfarin a úskalí jeho užití ve vyšším věku
Name in Czech Warfarin a úskalí jeho užití ve vyšším věku
Name (in English) Warfarin and its drawbacks when used in old age
Authors WEBER, Pavel, Hana MELUZÍNOVÁ, Hana KUBEŠOVÁ, Miroslav PENKA, Jana HRUBANOVÁ and Martina ŠLECHTOVÁ.
Edition Geriatria, Bratislava, 2006, 1335-1850.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Slovakia
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords in English warfarin; indications in old age; multi-morbidity; drug interactions; polypharmacy; bleeding
Tags bleeding, drug interactions, indications in old age, multi-morbidity, Polypharmacy, Warfarin
Tags Reviewed
Changed by Changed by: prof. MUDr. Pavel Weber, CSc., učo 37287. Changed: 8/9/2010 09:10.
Abstract
I ve stáří je dlouhodobá AT obvykle zahájována po zralé úvaze zejména z kardiologické indikace. Léčbu je vhodné pravidelně monitorovat a podle INR hodnot korigovat dávku warfarinu. Autoři pozorňují na některé aspekty, úskalí a rzika AT s rozvahou, zda lze předejít uvedeným komplikacím.
Abstract (in English)
AT may be usually initiated also in senior patients after due consideration, when the indications are mainly cardiological ones. The treatment has to be regularly monitored and warfarin dose has to be modified according to INR levels The autors also point at some aspects, drawbacks and risks of AT, while considering the prevention of the aforementioned complications.
PrintDisplayed: 31/5/2024 09:25